Grail Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Grail Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10423
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Grail Inc (Grail) provides a healthcare platform that develops devices to detect cancer at its early stages. The company uses population-scale clinical trials, data science, high-intensity sequencing and state of art of computer science to understand cancer biology and develop blood tests for early-stage cancer detection. Its platform produces data and transforms it into clinically actionable insights to classify patients according to presence, type, and severity of cancer. Grail’s clinical studies include Circulating cell-free genome atlas study (CCGA) and Strive study. It offers services to clinical research center. The company operates in the US and Hong Kong. Grail is headquartered in Menlo Park, California, the US.

Grail Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Grail Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Grail Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Grail Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Grail Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Grail Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Grail Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Grail Raises USD300 Million in Series C Financing 10
Grail Raises USD914 Million in First Tranche of Series B Financing 11
Grail Bio Raises USD100 Million in Series A Financing 13
Private Equity 14
Mubadala GE Capital and SoftBank Vision Fund May Acquire GRAIL 14
Partnerships 15
Yissum Enters into Agreement with GRAIL 15
Bristol-Myers Squibb Plans to Enter into Research Agreement with GRAIL 16
Merger 17
Grail Merges with Cirina 17
Equity Offering 18
Grail May Raise USD1 Billion in IPO 18
Grail Inc – Key Competitors 19
Grail Inc – Key Employees 20
Grail Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Corporate Communications 22
Oct 04, 2018: GRAIL names Renee Gala as Chief Financial Officer 22
Aug 09, 2018: GRAIL Announces Appointment of Hal Barron and Hans Bishop to its Board of Directors 23
Jul 09, 2018: GRAIL Announces Appointment of Key Executives as Company Makes Continued Progress in Development of Early Detection Products 24
Aug 02, 2017: GRAIL Appoints Chairman Bill Rastetter to Chief Executive Officer 26
May 04, 2017: GRAIL Announces Board of Directors Appointments 27
Product News 28
Oct 19, 2018: Grail to present new data from the Circulating Cell-free Genome Atlas (CCGA) study at the European Society for Medical Oncology (ESMO) 2018 Congress 28
Other Significant Developments 29
Nov 05, 2018: Striving for earlier cancer detection 29
Jul 31, 2017: GRAIL Selects AWS as its Cloud Provider 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Grail Inc, Medical Equipment, Key Facts 2
Grail Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Grail Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Grail Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Grail Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Grail Inc, Deals By Market, 2012 to YTD 2018 8
Grail Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Grail Raises USD300 Million in Series C Financing 10
Grail Raises USD914 Million in First Tranche of Series B Financing 11
Grail Bio Raises USD100 Million in Series A Financing 13
Mubadala GE Capital and SoftBank Vision Fund May Acquire GRAIL 14
Yissum Enters into Agreement with GRAIL 15
Bristol-Myers Squibb Plans to Enter into Research Agreement with GRAIL 16
Grail Merges with Cirina 17
Grail May Raise USD1 Billion in IPO 18
Grail Inc, Key Competitors 19
Grail Inc, Key Employees 20
Grail Inc, Other Locations 21

List of Figures
Grail Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Grail Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Grail Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Grail Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Grail Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Grail Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Grail Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Grail Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Grail Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • RWE Npower Holdings plc-エネルギー分野:企業M&A・提携分析
    Summary RWE Npower Holdings plc (RWE Npower), a subsidiary of RWE AG, is an energy utility that generates and supplies electricity and distributes gas in the UK. Through its subsidiaries, RWE Npower Group plc and RWE Generation UK plc, the company conducts electricity supply and generation respectiv …
  • Evolution Petroleum Corp (EPM):石油・ガス:M&Aディール及び事業提携情報
    Summary Evolution Petroleum Corp (EPC), a subsidiary of Esrey Resources Ltd, is an oil and gas company that acquires and explores crude oil and natural gas properties. The company explores for oil, liquefied gas, natural gas, and gas reserves in Delhi field CO2-EOR project. It offers GARP or gas ass …
  • Xencor Inc (XNCR):製薬・医療:M&Aディール及び事業提携情報
    Summary Xencor Inc (Xencor) is a clinical-stage biopharmaceutical company that develops engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer. The company provides pipeline products under preclinical development such as XmAb14045, for the …
  • Genisphere LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Genisphere LLC (Genisphere) is a nanotechnology company that provides DNA-based targeted drug delivery solutions. The company utilizes its proprietary 3DNA platform which enables the application in gene delivery, biologics, small molecules, and RNAi therapeutics. It develops pipeline product …
  • Betta Pharmaceuticals Co Ltd (300558):製薬・医療:M&Aディール及び事業提携情報
    Summary Betta Pharmaceuticals Co Ltd (Betta Pharma) is a pharmaceutical company that researches, develops, manufactures and markets drugs for the treatment of cancer, cardiovascular diseases and diabetes. The company offers icotinib hydrochloride, an orally administered small-molecule, reversible ty …
  • Sleep Number Corp (SNBR):企業の財務・戦略的SWOT分析
    Sleep Number Corp (SNBR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • CorMedix Inc (CRMD):企業の財務・戦略的SWOT分析
    Summary CorMedix Inc (CorMedix) is a commercial-stage pharmaceutical company that develops and commercializes therapeutic products for prevention and treatment of cardiac, renal and infectious diseases. The company offers neutrolin, a non-antibiotic anti-infective developed as a preventative solutio …
  • Abreos Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Abreos Biosciences Inc (Abreos) is a biotechnology company with focus on the development of laboratory-based and point-of-care (POC) assays and reagents for the precision dose monitoring of biologic drugs. Its Monator, is a drug-monitoring test that provides physicians with vital information …
  • Micell Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Micell Technologies Inc (Micell) is a medical device company that develops drug delivery systems for the treatment of cardiovascular diseases. The company provides product such as MiStent sirolimus eluting absorbable polymer coronary stent system, a drug-eluting stent that is designed to opt …
  • MOIL Ltd:企業の戦略・SWOT・財務分析
    MOIL Ltd - Strategy, SWOT and Corporate Finance Report Summary MOIL Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Daiwa Securities Group Inc:戦略・SWOT・企業財務分析
    Daiwa Securities Group Inc - Strategy, SWOT and Corporate Finance Report Summary Daiwa Securities Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Compania Espanola de Petroleos SAU-エネルギー分野:企業M&A・提携分析
    Summary Compania Espanola de Petroleos, S.A.U. (CEPSA) is an integrated energy company. It explores, produces, refines, transports and markets crude oil, petroleum products, and natural gas. It also produces and distributes electricity; manufactures, distributes, and sells basic petrochemicals, petr …
  • Polk-Burnett Electric Cooperative:企業の戦略的SWOT分析
    Polk-Burnett Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Senior Plc:企業の戦略・SWOT・財務情報
    Senior Plc - Strategy, SWOT and Corporate Finance Report Summary Senior Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Termas De Puyehue S.A.
    Termas De Puyehue S.A. - Strategy, SWOT and Corporate Finance Report Summary Termas De Puyehue S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Hibu Group Limited:戦略・SWOT・企業財務分析
    Hibu Group Limited - Strategy, SWOT and Corporate Finance Report Summary Hibu Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Dermira Inc (DERM):企業の財務・戦略的SWOT分析
    Summary Dermira Inc (Dermira) is a biopharmaceutical company that identifies, develops and commercializes therapeutic solutions for the treatment of dermatologic diseases, such as hyperhidrosis, acne vulgaris and atopic dermatitis. The company’s product includes QBREXZA (glycopyrronium) cloth, an an …
  • Cpp Group Plc (CPP):企業の財務・戦略的SWOT分析
    Summary Cpp Group Plc (CPP), is a provider of bespoke products and solutions. It offers flight disruption insurance, legal protection, autocare, assetcare and mobile phone insurance. It offers services such as airport angel, card rescue, card protection, packaged accounts and travel assistance. CPP …
  • Koninklijke Philips N.V. (PHIA)-医療機器分野:企業M&A・提携分析
    Summary Koninklijke Philips N.V. (Philips) is a diversified technology company which focuses on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The company develops and manufactures medical …
  • Detour Gold Corp
    Detour Gold Corp - Strategy, SWOT and Corporate Finance Report Summary Detour Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆